Today Commons Network publishes a new policy paper that takes on the pharmaceutical system and presents real alternatives, based on open source research and the knowledge commons. Commons Network proposes a new vision for the biomedical research system that safeguards universal access to affordable medicines and scientific advances.
Taking the commons perspective allows us to offer a diagnostic of our biomedical innovation system and to put forth a political programme for a transition to a new public interest model. The EU’s market-dominated pharmaceutical policies are sized up from the ‘outside the box’ viewpoint of the common good.
This paper responds to the questions: How does the present pharma model work in Europe, what is wrong with it and what can be done right now to change it. This includes a comparison between the existing model, positive transitions and the transformative commons model with practical examples, principles and outcomes.
Read the rest at the P2P Foundation blog
Go to the GEO front page
Add new comment